i-Port AdvanceTM
Let’s reduce the anxiety of injections together.
i-Port AdvanceTM is a subcutaneous injection port enabling the user to administer multiple daily injections.
Injection port can lead to improved HbA1C1
A paediatric diabetes study showed that children using an injection port can lower their HbA1C values by almost in just 6 months1.
Less pain2
i-Port AdvanceTM is applied quickly and virtually painlessly thanks to the serter.
Less anxiety2
i-Port AdvanceTM is a small injection port that allows the insertion of insulin without having to puncture the skin with each injection.
Improves quality of life3
i-Port AdvanceTM can be worn for 3 days* during all normal activities, such as showering, bathing or playing sports.
i-Port AdvanceTM helps improve glycemic control
Patients using a subcutaneous injection port can achieve a reduction in HbA1c levels of approximately 1% in just 6 months, compared to those using standard injections
Simple to apply, easy to use
Suitable for various types of patients, including adults and children, for the subcutaneous administration of medications prescribed by a doctor
Compatible with both a pen and a syringe (it is recommended to use needles with a length between 5 and 8 mm)
Can remain in place for a maximum of 3 days (72 hours) to allow multiple injections
Can be worn during normal daily activities.
With i-Port Advance™, only one injection is needed every three days
After application, multiple injections can be administered
Footnotes
* Do not inject more than 75 times through a single device. - Product CE marked by Unomedical a/s. - This information does not substitute the Instructions for Use/User Guide - For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use
References
1. Burdick P, Cooper S, Horner B, Cobry E, McFann K, Chase HP. Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes. Pediatr Diabetes. 2009;10:116–119.
2. Hanas R, Adolfsson P, Elfvin-Akesson K et al. Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety. J Pediatr. 2002;140(3)315-320
3. Rabbone I, Bobbio A, Di Gianni V, Sacchetti C, Cerutti F. Intensive insulin therapy in preschool-aged diabetic children from multiple daily injections to continuous subcutaneous insulin infusion through indwelling catheters. J Endocrinol Invest. 2008;3 (3):193-195
Please note that this platform has been developed for UK Healthcare Professionals. Content may not be aligned with local regulations, approvals, or practices in your country. Please contact your MiniMed representative for further information.